Vimarsana
Biggest News Aggregation in the World

Page 3 - Regulating Stem Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulating Stem Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulating Stem Cells Today - Breaking & Trending Today

Hemostemix Inc.: Hemostemix to Combine ACP-01 with Dr. James Shapiro's Islet Cells to Treat Type 1 Diabetes - Vimarsana News

Hemostemix Inc.: Hemostemix to Combine ACP-01 with Dr. James Shapiro's Islet Cells to Treat Type 1 Diabetes

Calgary, Alberta--(Newsfile Corp. - January 11, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it has signed a contract with Dr.

Hemostemix Inc.: Hemostemix Announces Soft Lock of Database as Source Document Verification Completed - Vimarsana News

Hemostemix Inc.: Hemostemix Announces Soft Lock of Database as Source Document Verification Completed

Calgary, Alberta--(Newsfile Corp. - December 9, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB :HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the source document verification process

Hemostemix Inc.: Hemostemix Confirms OTCQB Listing - Vimarsana News

Hemostemix Inc.: Hemostemix Confirms OTCQB Listing

Calgary, Alberta--(Newsfile Corp. - October 28, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it is now up-listed to trade on the

Hemostemix Inc.: Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer - Vimarsana News

Hemostemix Inc.: Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer

Calgary, Alberta--(Newsfile Corp. - October 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Fraser C. Henderson

Hemostemix Inc.: Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain - Vimarsana News

Hemostemix Inc.: Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain

Calgary, Alberta--(Newsfile Corp. - October 4, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the second in its series of video interviews with